Nitric Oxide Modulation of the Dopaminergic Nigrostriatal System: Focus on Nicotine Action
Nitric oxide (NO) signalling plays an important role in the integration of information processed by the basal ganglia nuclei. Accordingly, considerable evidence has emerged indicating a role for NO in pathophysiological conditions such as Parkinson’s disease (PD), schizophrenia and drug addiction. To further investigate the NO modulation of dopaminergic function in the basal ganglia circuitry, in this study we used in vivo electrophysiology and microdialysis in freely-moving rats. Pharmacological manipulation of the NO system did not cause any significant changes either in the basal firing rate and bursting activity of the dopamine (DA) neurons in the substantia nigra pars compacta (SNc) or in DA release in the striatum. In contrast, the disruption of endogenous NO tone was able to counteract the phasic dopaminergic activation induced by nicotine treatment in both experimental approaches. These results further support the possibility that nicotine acts via a NO mechanism and suggest a possible state-dependent facilitatory control of NO on the nigrostriatal DA pathway. Thus, NO selectively modulates the DA exocytosis associated with increased DA functiov n.
KeywordsNitric Oxide Globus Pallidus Burst Firing DAergic Neuron Dopaminergic Nigrostriatal System
This study was supported in part by Ateneo di Palermo research funding project ORPA068JJ5 (coordinator G. Di Giovanni).
- Del Bel EA, Bermúdez-Echeverry M, Salum C and Raisman-Vozari R (2007) Nitric oxide system and basal ganglia physiopathology. In: Di Giovanni G (ed) The Basal Ganglia Pathophysiology: Recent Advances. Transworld Research Network, Kerala, India, pp. 129–158.Google Scholar
- De Vente J, Markerink-van Ittersum M, van Abeelen J, Emson PC, Axer H and Steinbusch HW (2000) NO-mediated cGMP synthesis in cholinergic neurons in the rat forebrain: effects of lesioning dopaminergic or serotonergic pathways on nNOS and cGMP synthesis. Eur J Neurosci 12: 507–519.CrossRefPubMedGoogle Scholar
- Di Giovanni G, De Deurwaerdére P, Di Mascio M, Di Matteo V, Esposito E and Spampinato U (1999) Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91: 587–597.CrossRefPubMedGoogle Scholar
- Di Giovanni G, Ferraro G, Sardo P, Di Maio R, Carletti F and La Grutta V (2006) Microiontophoretic evidence that nitric oxide alters spontaneous activity of the substantia nigra pars reticulata neurons in the rat. Acta Physiol 188 (Suppl 652): P184.Google Scholar
- Di Matteo V, Pierucci M, Benigno A, Crescimanno G, Esposito E and Di Giovanni G (2009) Involvement of nitric oxide in 6-OHDA-induced neurodegeneration: an ex vivo study. Ann NY Acad Sci 1155: 309–315.Google Scholar
- Fricchione G and Stefano GB (2005) Placebo neural systems: nitric oxide, morphine and the dopamine brain reward and motivation circuitries. Med Sci Monit 11: 54–65.Google Scholar